L3VLUP
ProSign in

TGTX · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

TGTXLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • TGTX
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterTGTXLLY
Q3 20203 holders, $416m33 holders, $14.1bn
Q4 20207 holders, $1.3bn29 holders, $17.3bn
Q1 20216 holders, $1.4bn24 holders, $23.0bn
Q2 20216 holders, $1.2bn24 holders, $27.8bn
Q3 20214 holders, $893m31 holders, $29.9bn
Q4 20212 holders, $194m31 holders, $34.7bn
Q1 20222 holders, $74m24 holders, $35.3bn
Q2 20222 holders, $29m33 holders, $42.7bn
Q3 20222 holders, $51m31 holders, $43.4bn
Q4 20225 holders, $108m31 holders, $46.6bn
Q1 20233 holders, $55m33 holders, $44.3bn
Q2 20237 holders, $154m37 holders, $59.6bn
Q3 20235 holders, $47m44 holders, $67.6bn
Q4 20232 holders, $36m45 holders, $73.6bn
Q1 20243 holders, $37m41 holders, $95.3bn
Q2 20246 holders, $109m43 holders, $110bn
Q3 20246 holders, $94m45 holders, $107bn
Q4 20243 holders, $2.7m46 holders, $93.9bn
Q1 20255 holders, $57m42 holders, $98.4bn
Q2 20254 holders, $49m43 holders, $93.2bn
Q3 20256 holders, $102m39 holders, $86.7bn
Q4 20256 holders, $83m41 holders, $123bn
Q1 20265 holders, $88m39 holders, $106bn
Q2 20268 holders, $445m44 holders, $132bn
TGTX

TG Therapeutics Inc

Holders
6
Reported value
$109m
Buyers
6
Sellers
0

Breadth +6 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
LLY

Eli Lilly & Co

Holders
43
Reported value
$110bn
Buyers
29
Sellers
17

Breadth +12 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2024

Among the 44 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only TGTX (1)

Brevan Howard Capital Management LP

Only LLY (38)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, Coatue Management LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Holocene Advisors LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, Neuberger Berman Group LLC, and 13 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →